Trial Profile
Protocol for Specified Drug Use-results Survey of Betanis Tablets (for Patients With Coexisting Cardiovascular Disease)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2018
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Cardiovascular disorders; Overactive bladder
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society
- 10 Oct 2015 New trial record